Holen Sie sich die Stockscreener-App
77.55
2.39%
-1.90
Vorhandelsmarkt:
77.70
0.15
+0.19%
Schlusskurs vom Vortag:
$79.45
Offen:
$79.28
24-Stunden-Volumen:
15.77M
Relative Volume:
1.40
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.49%
1M Leistung:
+4.33%
6M Leistung:
-22.46%
1J Leistung:
-13.72%
1-Tages-Spanne:
$77.20
$79.44
1-Wochen-Bereich:
$75.68
$80.07
52-Wochen-Spanne:
$66.66
$105.47
Spdr Biotech Etf Stock (XBI) Company Profile
Firmenname
Spdr Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XBI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBI
Spdr Biotech Etf
|
77.55 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
289.22 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
586.84 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
589.94 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
232.94 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
515.59 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf Aktie (XBI) Neueste Nachrichten
Zacks Investment Ideas feature highlights: Alibaba, JD.com, SPDR S&P Biotech ETF, Merck and Microsoft - Yahoo Finance
XBI: Some Tariff Relief Right Now, But Macro Risks Remain In Biotech (NYSEARCA:XBI) - Seeking Alpha
MBB Leads With $1.2B Gain as Markets React to UK Trade Deal - TradingView
XBI, EXAS, ALNY, NTRA: Large Outflows Detected at ETF - Nasdaq
(XBI) Investment Analysis - news.stocktradersdaily.com
XBI, Biotech Stocks Retreat: Buy, Hold or Sell? - ETF.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
SPDR S&P Biotech ETF Target of Unusually High Options Trading (NYSEARCA:XBI) - Defense World
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Optimism is Back for Biotech Stocks. This Time, It Could Last. - MSN
Optimism Is Back for Biotech Stocks. This Time, It Could Last. - Barron's
Renaissance Technologies LLC Purchases Shares of 5,500 SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Should You Invest in the VanEck Biotech ETF (BBH)? - Nasdaq
ETFs That Outperform the S&P 500: ARKK, VGT, IWF, XBI - Markets.com
(XBI) On The My Stocks Page - news.stocktradersdaily.com
Alliancebernstein L.P. Makes New Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 Best Health Care Funds and ETFs for 2025 | Investing | U.S. News - Money/ US News
O Shaughnessy Asset Management LLC Has $65,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Biotech stocks to own amid market volatility – Piper Sandler (XBI:NYSEARCA) - Seeking Alpha
Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets - Yahoo Finance
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
How the (XBI) price action is used to our Advantage - news.stocktradersdaily.com
Should You Invest in the iShares Biotechnology ETF (IBB)? - Nasdaq
11 Stocks to Buy After the Biotech Bloodbath - Barron's
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies - Asianet Newsable
Wednesday's ETF Movers: XBI, PICK - Nasdaq
XBI Crosses Critical Technical Indicator - Nasdaq
Analysts at Cantor, formerly headed by Lutnick, call for Kennedy's dismissal - Reuters
Biotech stocks plunge as FDA’s Peter Marks resigns over RFK Jr. dispute, Moderna and Beam Therapeutics hit hard - TradingView
Bank of New York Mellon Corp Reduces Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Long Term Trading Analysis for (XBI) - news.stocktradersdaily.com
Trump administration cancels $12 billion in funding to state health departments (XBI:NYSEARCA) - Seeking Alpha
Proficio Capital Partners LLC Buys 5,225 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq
Sequoia Financial Advisors LLC Trims Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
How Is Biogen's Stock Performance Compared to Other Biotech Stocks? - TradingView
(XBI) Investment Report - Stock Traders Daily
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank - Armenian Reporter
Assetmark Inc. Sells 588,528 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Healthcare Sector Trying To Bounce Back - Seeking Alpha
Atria Investments Inc Buys 1,043 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
2Seventy Bio (TSVT): Surge Following Acquisition Announcement - Value The Markets
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by US Bancorp DE - Defense World
Form 424B2 MORGAN STANLEY - StreetInsider.com
Steward Partners Investment Advisory LLC Sells 814 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
(XBI) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Guarantor: JPMorgan Chase & Co. - StreetInsider.com
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value the Markets
Finanzdaten der Spdr Biotech Etf-Aktie (XBI)
Es liegen keine Finanzdaten für Spdr Biotech Etf (XBI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.49%
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):